This article has been updated from a previous version to correct the amount of GE's offer for Abbott.
 
NEW YORK (GenomeWeb News) – Abbott Laboratories disclosed in a filing with the US Securities and Exchange Commission today that it would cut costs in its global diagnostics business through a plan expected to yield annual pre-tax savings of more than $150 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.